The Russia Viscosupplementation Market, a treatment for osteoarthritis, is poised for steady growth. According to a recent analysis by Future Market Insights (FMI), the market is expected to reach a valuation of USD 84.86 million by 2032. This reflects a Compound Annual Growth Rate (CAGR) of 6.2% through the forecast period, indicating a sustained demand for these treatments.
Key Findings from the “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026” Report:
- Market Dominated by 3-Injection Treatments: In 2016, nearly 70% of Russia’s viscosupplementation market revenue came from 3-injection treatment options.
- Strong Growth Trajectory: The report estimates Russia’s viscosupplementation market generated over USD 19 million in 2016.
- CAGR of 5.8% Projected: FMI predicts continued growth, with revenues expected to reach US$34 million by 2026.
With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single-injection and five-injection viscosupplementation products.
Request a Sample of this Report Now!
Russia’s healthcare infrastructure will continue witnessing a significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia Viscosupplementation Industry conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.
The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.
Top Players in Russia’s Viscosupplementation Market
The top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues.
International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia Viscosupplementation Industry
Ask For Customization For this Report!
The Russia Viscosupplementation Market is divided into two segments based on product type and end use:
By Product Type
- Single Injection Viscosupplementation
- Three Injection Viscosupplementation
- Five Injection Viscosupplementation
By End Use
- Hospitals
- 500+ Bedded
- 250-500 Bedded
- Less Than 250 Bedded
- Ambulatory Surgical Centres
- Orthopaedic Clinics
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
